Alliancebernstein L.P. Cuts Stock Holdings in Docusign Inc. $DOCU

Key Points

• Alliancebernstein L.P. reduced its position in Docusign Inc. by 1.5%, selling 5,629 shares and now owns approximately 0.18% of the company worth $30.37 million.
• Several institutional investors have adjusted their stakes in Docusign, with Bessemer Group Inc. increasing its holdings by 27.5%, while hedge funds and institutional investors own 77.64% of the company's stock.
• Docusign reported a net income increase for the quarter, achieving $0.92 earnings per share on revenue of $800.64 million, exceeding the consensus estimates.

Alliancebernstein L.P. decreased its holdings in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 1.5% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 373,151 shares of the company's stock after selling 5,629 shares during the period. Alliancebernstein L.P. owned approximately 0.18% of Docusign worth $30,374,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DOCU. Banque Transatlantique SA acquired a new position in Docusign during the 1st quarter worth approximately $26,000. Hemington Wealth Management increased its holdings in Docusign by 318.1% in the first quarter. Hemington Wealth Management now owns 347 shares of the company's stock valued at $28,000 after buying an additional 264 shares in the last quarter. Golden State Wealth Management LLC increased its holdings in Docusign by 519.4% in the first quarter. Golden State Wealth Management LLC now owns 384 shares of the company's stock valued at $31,000 after buying an additional 322 shares in the last quarter. Summit Securities Group LLC purchased a new position in Docusign in the first quarter valued at about $34,000. Finally, Wood Tarver Financial Group LLC purchased a new stake in shares of Docusign during the 4th quarter worth approximately $37,000. Institutional investors and hedge funds own 77.64% of the company's stock.

Insiders Place Their Bets

In related news, Director Teresa Briggs sold 364 shares of the company's stock in a transaction on Thursday, September 11th. The stock was sold at an average price of $79.39, for a total value of $28,897.96. Following the completion of the transaction, the director directly owned 9,170 shares in the company, valued at approximately $728,006.30. This represents a 3.82% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Blake Jeffrey Grayson sold 15,143 shares of the stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.80, for a total value of $1,132,696.40. Following the transaction, the chief financial officer owned 110,723 shares in the company, valued at $8,282,080.40. This trade represents a 12.03% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 79,365 shares of company stock worth $6,050,856 over the last ninety days. Company insiders own 1.66% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently commented on DOCU. Zacks Research raised Docusign from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, September 9th. UBS Group set a $95.00 price target on Docusign in a research note on Friday, September 5th. Wells Fargo & Company boosted their price target on Docusign from $80.00 to $85.00 and gave the stock an "equal weight" rating in a research note on Friday, September 5th. Evercore ISI boosted their price target on Docusign from $90.00 to $92.00 and gave the stock an "in-line" rating in a research note on Friday, September 5th. Finally, Citigroup boosted their price target on Docusign from $110.00 to $115.00 and gave the stock a "buy" rating in a research note on Thursday, September 4th. One investment analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating and fourteen have given a Hold rating to the company's stock. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $94.14.

Docusign Stock Performance

DOCU stock traded up $1.38 on Monday, reaching $81.57. The company had a trading volume of 2,750,849 shares, compared to its average volume of 3,121,919. Docusign Inc. has a 1 year low of $55.14 and a 1 year high of $107.86. The company's fifty day moving average is $75.82 and its 200 day moving average is $79.21. The company has a market cap of $16.40 billion, a P/E ratio of 61.33, a PEG ratio of 4.20 and a beta of 1.02.

Docusign (NASDAQ:DOCU - Get Free Report) last posted its earnings results on Thursday, September 4th. The company reported $0.92 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.84 by $0.08. Docusign had a return on equity of 14.01% and a net margin of 9.08%.The firm had revenue of $800.64 million for the quarter, compared to analyst estimates of $780.35 million. During the same quarter in the prior year, the company earned $0.97 EPS. Docusign's revenue was up 8.8% on a year-over-year basis. Docusign has set its Q3 2026 guidance at EPS. FY 2026 guidance at EPS. On average, sell-side analysts predict that Docusign Inc. will post 1.17 earnings per share for the current year.

Docusign announced that its board has initiated a stock buyback program on Thursday, June 5th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the company to repurchase up to 6.6% of its shares through open market purchases. Shares repurchase programs are usually a sign that the company's board believes its shares are undervalued.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.